JUL 26, 2017 04:12 PM PDT

Immune Cells Compete Against Each Other for Survival

WRITTEN BY: Kara Marker

A study that was initially designed to simply study T cell homeostasis ended up yielding surprising results. A recently discovered cell type, innate lymphoid cells (ILCs), appeared to be better at securing proteins both ILCs and T cells need to survive. This finding is perplexing because while T cells are plentiful in the body, ILCs are extremely rare.

Innate lymphoid cells (ILCs, in gray) outcompete and exert a measurable control on the survival of the abundant T-cells (pink). This is possible because T cells decrease the number of IL-7 receptors (IL-7R, represented as butterfly nets) after binding IL-7, while ILCs do not. Credits: IBS, modified from freepiks.com

The study was a collaboration between the Institute for Basic Science, La Jolla Institute for Allergy and Immunology, and The Scripps Research Institute. Researchers are interested in understanding more about immune cell homeostasis, especially T cells and B cells, due to their vital role in vaccine effectiveness and in keeping the human body health even as it ages.

T cells need to bind a protein called interleukin-7 (IL-7) to survive, and they have an IL-7 receptor on their cell surface just for this purpose. In the past, scientists had trouble studying T cell homeostasis because it is difficult to measure levels of IL-7 in the lab. But in the current study, scientists found a way around this roadblock to study how the body regulates IL-7 production.

Starting with mice lacking any IL-7 receptors, researchers saw IL-7 proteins begin to accumulate in the mice models, since they had nothing to bind. Then, they reintroduced cells with IL-7 receptors and watched how the mice immune systems reacted. This is where they saw that T cells were not the only cell binding IL-7; ILCs were also binding IL-7 and binding it more effectively.

"To be honest, I was quite surprised that ILCs have such an effect in this model," said lead author, Christopher Martin. "Relative to T cells, there are very few ILCs in the tissues we study. So, when we were designing the initial experiments, we weren't optimistic that we would find anything interesting."

Now with ILCs in the picture, we have to wonder: Why isn’t there enough IL-7 for both these cells? Why do they need to compete? While these questions have yet to be answered, the study scientists do know why ILCs are better at binding IL-7. While T cells decrease the number of IL-7 receptors as they start to bind IL-7, ILC’s don’t, and they can continue binding IL-7 at a rate faster than T cells.

Creating healthy levels of both T cells and ILCs is important for fighting pathogens, making vaccines work, and preparing for good health in old age, when natural production of immune cells slowly diminishes. If scientists can understand why these two cell types have to compete for survival, perhaps they can find a way for both to flourish in harmony.

The present study was published in the journal Immunity.

 

Source: Institute for Basic Science

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 03, 2018
Cardiology
MAY 03, 2018
Immune Cells and Heart Disease: Helpful or Harmful?
Depending on where an immune cell is during injury to the heart, like during a heart attack, their activity can either be harmful or helpful. From Case Wes...
MAY 10, 2018
Immunology
MAY 10, 2018
New Biomarker for Lung Cancer Diagnosis
Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic...
JUN 12, 2018
Immunology
JUN 12, 2018
Auto-antibody Detection for Rheumatoid Arthritis Patients
No case of rheumatoid arthritis (RA), an autoimmune disease, is the same. Now, researchers want RA diagnostic approaches to match its pathological diversit...
JUN 22, 2018
Health & Medicine
JUN 22, 2018
A New Test for Peanut Allergy: Better, Faster, Cheaper.
Scientists from the Medical Research Council (MRC) in the UK have come up with a test to detect peanut allergies and it’s safer, quicker and more acc...
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Discovery of New Properties of an Anti-Tuberculosis Drug
  Investigators at the University of Otago found novel properties of a new anti-tuberculosis drug which may inspire more new drugs to treat tuberculos...
JUL 08, 2018
Microbiology
JUL 08, 2018
Natural Molecule has a Potent Anti-inflammatory Impact
A compound that is naturally made by a bacterium called Francisella tularensis can impair the immune response....
Loading Comments...